Teaching an old dog new tricks: reactivated developmental signaling pathways regulate ABCB1 and chemoresistance in cancer

Abstract

Oncogenic multidrug resistance (MDR) is a multifactorial phenotype intimately linked to deregulated expression of detoxification transporters. Drug efflux transporters, particularly the MDR P-glycoprotein ABCB1, represent a central mechanism by which not only chemotherapeutic drugs are extruded or sequestered to prevent drug delivery to their intracellular targets, but also for inhibiting apoptotic cell death cues, such as removal of proapoptotic signals. Several cell populations exhibiting the MDR phenotype co-exist within a tumor, such as cells forming the bulk tumor cell mass, cancer stem cells, and cancer persister cells. The key to regulation of ABCB1 expression is the cellular transcriptional machinery. Developmental signaling pathways (e.g, Hedgehog, Notch, Wnt/β-catenin, TGFβ, PITX2) are pivotal in governing cell proliferation, survival, differentiation and guiding cell migration during embryogenesis, and their reactivation during carcinogenesis, which is of particular significance for tumor initiation, progression, and metastasis, also leads to the upregulation of ABCB1. These pathways also drive and maintain cancer cell stemness, for which ABCB1 is used as a marker. In this review, the contribution of canonical and non-canonical developmental signaling pathways in transcriptional regulation of ABCB1 to confer MDR in cancer is delineated.

Keywords

Drug resistance / ABC transporters / transforming growth factor beta / tumor heterogeneity / tumor cell biology

References

[1] Hyde SC,Hartshorn MJ.Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport..Nature1990;346:362-5

[2] Christakis P.The birth of chemotherapy at Yale. Bicentennial lecture series: Surgery Grand Round..Yale J Biol Med2011;84:169-72 PMCID:PMC3117414

[3] Biedler JL.Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies..Cancer Res1970;30:1174-84

[4] Ling V.Drug resistance and membrane alteration in mutants of mammalian cells..Can J Genet Cytol1975;17:503-15

[5] Juliano RL.A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants..Biochim Biophys Acta1976;455:152-62

[6] Karthikeyan S.Development of Fourth Generation ABC Inhibitors from Natural Products: A Novel Approach to Overcome Cancer Multidrug Resistance..Anticancer Agents Med Chem2015;15:605-15

[7] Genovese I,Assaraf YG,Colotti G.Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins..Drug Resist Updat2017;32:23-46

[8] Lee WK.Sphingolipid abnormalities in cancer multidrug resistance: Chicken or egg?.Cell Signal2017;38:134-45 PMCID:PMC5726251

[9] Nobili S,Landini I,Roviello G.Role of ATP-binding cassette transporters in cancer initiation and progression..Semin Cancer Biol2020;60:72-95

[10] Han LW,Mao Q.An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus..Expert Opin Drug Metab Toxicol2018;14:817-29 PMCID:PMC6290921

[11] Huang QT,Kibschull M.P-glycoprotein expression and localization in the rat uterus throughout gestation and labor..Reproduction2016;152:195-204

[12] Dempke WCM,Uciechowski P.Targeting Developmental Pathways: The Achilles Heel of Cancer?.Oncology2017;93:213-23

[13] Franco C.Recent proteomic advances in developmental, regeneration, and cancer governing signaling pathways..Proteomics2015;15:1014-25

[14] Takebe N,Harris PJ.Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update..Nat Rev Clin Oncol2015;12:445-64 PMCID:PMC4520755

[15] Gottesman MM,Bates SE.Multidrug resistance in cancer: role of ATP-dependent transporters..Nat Rev Cancer2002;2:48-58

[16] Borst P.P-glycoprotein ABCB1: a major player in drug handling by mammals..J Clin Invest2013;123:4131-3 PMCID:PMC3784548

[17] Ambudkar SV,Sauna ZE.P-glycoprotein: from genomics to mechanism..Oncogene2003;22:7468-85

[18] Chen Y.In situ biochemical demonstration that P-glycoprotein is a drug efflux pump with broad specificity..J Cell Biol2000;148:863-70 PMCID:PMC2174548

[19] Shapiro AB.The mechanism of ATP-dependent multidrug transport by P-glycoprotein..Acta Physiol Scand Suppl1998;643:227-34

[20] Alvarez M,Monks A.Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen..J Clin Invest1995;95:2205-14 PMCID:PMC295832

[21] van Helvoort A,Sprong H.MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine..Cell1996;87:507-17

[22] Eckford PD.The reconstituted P-glycoprotein multidrug transporter is a flippase for glucosylceramide and other simple glycosphingolipids..Biochem J2005;389:517-26 PMCID:PMC1175130

[23] Lee WK,Kohistani N.ABCB1 protects kidney proximal tubule cells against cadmium-induced apoptosis: roles of cadmium and ceramide transport..Toxicol Sci2011;121:343-56

[24] Chen CJ,Ueda K.Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells..Cell1986;47:381-9

[25] Gros P,Housman D.Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins..Cell1986;47:371-80

[26] Aller SG,Ward A.Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding..Science2009;323:1718-22 PMCID:PMC2720052

[27] Loo TW,Clarke DM.Simultaneous binding of two different drugs in the binding pocket of the human multidrug resistance P-glycoprotein..J Biol Chem2003;278:39706-10

[28] Chen Y,Simon SM.P-glycoprotein does not reduce substrate concentration from the extracellular leaflet of the plasma membrane in living cells..Cancer Res2001;61:7763-9

[29] Loo TW.Functional consequences of phenylalanine mutations in the predicted transmembrane domain of P-glycoprotein..J Biol Chem1993;268:19965-72

[30] Raviv Y,Bruggemann EP,Gottesman MM.Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells..J Biol Chem1990;265:3975-80

[31] Qu Q.Proximity of bound Hoechst 33342 to the ATPase catalytic sites places the drug binding site of P-glycoprotein within the cytoplasmic membrane leaflet..Biochemistry2002;41:4744-52

[32] Eytan GD.Mechanism of multidrug resistance in relation to passive membrane permeation..Biomed Pharmacother2005;59:90-7

[33] Rauch C.The “multi” of drug resistance explained by oscillating drug transporters, drug-membrane physical interactions and spatial dimensionality..Cell Biochem Biophys2011;61:103-13

[34] Omote H.Interaction of transported drugs with the lipid bilayer and P-glycoprotein through a solvation exchange mechanism..Biophys J2006;90:4046-59 PMCID:PMC1459527

[35] Clay AT.Lipid bilayer properties control membrane partitioning, binding, and transport of p-glycoprotein substrates..Biochemistry2013;52:343-54

[36] Seelig A.Structure-activity relationship of P-glycoprotein substrates and modifiers..Eur J Pharm Sci2000;12:31-40

[37] Shapiro AB.Extraction of Hoechst 33342 from the cytoplasmic leaflet of the plasma membrane by P-glycoprotein..Eur J Biochem1997;250:122-9

[38] Shapiro AB.Transport of LDS-751 from the cytoplasmic leaflet of the plasma membrane by the rhodamine-123-selective site of P-glycoprotein..Eur J Biochem1998;254:181-8

[39] Breier A,Sulova Z.P-glycoprotein--implications of metabolism of neoplastic cells and cancer therapy..Curr Cancer Drug Targets2005;5:457-68

[40] Scotto KW.Transcriptional regulation of ABC drug transporters..Oncogene2003;22:7496-511

[41] Clevers H.Wnt/beta-catenin signaling and disease..Cell2012;149:1192-205

[42] Lee WK,Thévenod F.Pituitary homeobox 2 (PITX2) protects renal cancer cell lines against doxorubicin toxicity by transcriptional activation of the multidrug transporter ABCB1..Int J Cancer2013;133:556-67

[43] Lee WK.Oncogenic PITX2 facilitates tumor cell drug resistance by inverse regulation of hOCT3/SLC22A3 and ABC drug transporters in colon and kidney cancers..Cancer Lett2019;449:237-51

[44] Shapiro AB,Lee P,Ling V.Functional intracellular P-glycoprotein..Int J Cancer1998;76:857-64

[45] Yamagishi T,Sharp DM,Jansson PJ.P-glycoprotein mediates drug resistance via a novel mechanism involving lysosomal sequestration..J Biol Chem2013;288:31761-71 PMCID:PMC3814770

[46] Calcabrini A,Stringaro A,Arancia G.Detection of P-glycoprotein in the nuclear envelope of multidrug resistant cells..Histochem J2000;32:599-606

[47] Seidel A,Loser R.Intracellular localization, vesicular accumulation and kinetics of daunorubicin in sensitive and multidrug-resistant gastric carcinoma EPG85-257 cells..Virchows Arch1995;426:249-56

[48] Crivellato E,Rosati AM,Klugmann FB.Kinetics of doxorubicin handling in the LLC-PK1 kidney epithelial cell line is mediated by both vesicle formation and P-glycoprotein drug transport..Histochem J1999;31:635-43

[49] Bobichon H,Depierreux C,Jardillier JC.Ultrastructural changes related to multidrug resistance in CEM cells: role of cytoplasmic vesicles in drug exclusion..J Exp Ther Oncol1996;1:49-61

[50] Katayama K,Ohnuma S.Revealing the fate of cell surface human P-glycoprotein (ABCB1): The lysosomal degradation pathway..Biochim Biophys Acta2015;1853:2361-70 PMCID:PMC4558211

[51] Al-Akra L,Sahni S.Tumor stressors induce two mechanisms of intracellular P-glycoprotein-mediated resistance that are overcome by lysosomal-targeted thiosemicarbazones..J Biol Chem2018;293:3562-87 PMCID:PMC5846167

[52] Stefan SM,Kalinowski DS,Dharmasivam M.The growing evidence for targeting P-glycoprotein in lysosomes to overcome resistance..Future Med Chem2020;12:473-7

[53] Molinari A,Meschini S.Subcellular detection and localization of the drug transporter P-glycoprotein in cultured tumor cells..Curr Protein Pept Sci2002;3:653-70

[54] Szaflarski W,Januchowski R.Nuclear localization of P-glycoprotein is responsible for protection of the nucleus from doxorubicin in the resistant LoVo cell line..Biomed Pharmacother2013;67:497-502

[55] Sharom FJ.Complex Interplay between the P-Glycoprotein Multidrug Efflux Pump and the Membrane: Its Role in Modulating Protein Function..Front Oncol2014;4:41 PMCID:PMC3939933

[56] Brown DA.Lipid rafts, detergent-resistant membranes, and raft targeting signals..Physiology (Bethesda)2006;21:430-9

[57] Simons K.Membrane organization and lipid rafts..Cold Spring Harb Perspect Biol2011;3:a004697 PMCID:PMC3179338

[58] Lavie Y,Liscovitch M.Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells..J Biol Chem1998;273:32380-3

[59] Klappe K,Hoekstra D.Lipid dependence of ABC transporter localization and function..Chem Phys Lipids2009;161:57-64

[60] Wang E,Clement RP.Cholesterol interaction with the daunorubicin binding site of P-glycoprotein..Biochem Biophys Res Commun2000;276:909-16

[61] Fenyvesi F,Szente L.P-glycoprotein inhibition by membrane cholesterol modulation..Eur J Pharm Sci2008;34:236-42

[62] Troost J,Haefeli WE.Modulation of cellular cholesterol alters P-glycoprotein activity in multidrug-resistant cells..Mol Pharmacol2004;66:1332-9

[63] Modok S,Callaghan R.P-glycoprotein retains function when reconstituted into a sphingolipid- and cholesterol-rich environment..J Lipid Res2004;45:1910-8

[64] Deng B,Cook PR.Transcription factories, chromatin loops, and the dysregulation of gene expression in malignancy..Semin Cancer Biol2013;23:65-71

[65] Martinez E.Multi-protein complexes in eukaryotic gene transcription..Plant Mol Biol2002;50:925-47

[66] Gromnicova R,Male D.Transcriptional control of the multi-drug transporter ABCB1 by transcription factor Sp3 in different human tissues..PLoS One2012;7:e48189 PMCID:PMC3485001

[67] Lettnin AP,Carrett-Dias M.Silencing the OCT4-PG1 pseudogene reduces OCT-4 protein levels and changes characteristics of the multidrug resistance phenotype in chronic myeloid leukemia..Mol Biol Rep2019;46:1873-84

[68] Asakura K,Miyachi H.TEL/AML1 overcomes drug resistance through transcriptional repression of multidrug resistance-1 gene expression..Mol Cancer Res2004;2:339-47

[69] Lutterbach B,Schuetz J.The MYND motif is required for repression of basal transcription from the multidrug resistance 1 promoter by the t(8;21) fusion protein..Mol Cell Biol1998;18:3604-11 PMCID:PMC108942

[70] Ando T,Oka Y.Decitabine (5-Aza-2’-deoxycytidine) decreased DNA methylation and expression of MDR-1 gene in K562/ADM cells..Leukemia2000;14:1915-20

[71] El-Osta A,Wolffe AP.Profiling methyl-CpG specific determinants on transcriptionally silent chromatin..Mol Biol Rep2001;28:209-15

[72] Ogretmen B.Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region..Biochemistry1999;38:2189-99

[73] Christie EL,Beach J.Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer..Nat Commun2019;10:1295 PMCID:PMC6426934

[74] Kumar R,Muller S.Epigenomic regulation of oncogenesis by chromatin remodeling..Oncogene2016;35:4423-36

[75] Moro H,Nakamura Y.Epigenetic priming sensitizes gastric cancer cells to irinotecan and cisplatin by restoring multiple pathways..Gastric Cancer2020;23:105-15

[76] Patch AM,Etemadmoghadam D.Whole-genome characterization of chemoresistant ovarian cancer..Nature2015;521:489-94

[77] Sauna ZE,Ambudkar SV.Genomics and the mechanism of P-glycoprotein (ABCB1)..J Bioenerg Biomembr2007;39:481-7

[78] Wolking S,Lerche H,Nies AT.Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature..Clin Pharmacokinet2015;54:709-35

[79] Huff LM,Robey RW.Characterization of gene rearrangements leading to activation of MDR-1..J Biol Chem2006;281:36501-9

[80] Rund D,Shperling O.A mutation in the promoter of the multidrug resistance gene (MDR1) in human hematological malignancies may contribute to the pathogenesis of resistant disease..Adv Exp Med Biol1999;457:71-5

[81] Reed K,Sprowl JA.The temporal relationship between ABCB1 promoter hypomethylation, ABCB1 expression and acquisition of drug resistance..Pharmacogenomics J2010;10:489-504

[82] Huo H,Pietsch EC,Scotto KW.Histone methyltransferase MLL1 regulates MDR1 transcription and chemoresistance..Cancer Res2010;70:8726-35 PMCID:PMC5675022

[83] Yague E,Harrison G.P-glycoprotein (MDR1) expression in leukemic cells is regulated at two distinct steps, mRNA stabilization and translational initiation..J Biol Chem2003;278:10344-52

[84] McGranahan N.Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future..Cell2017;168:613-28

[85] Yuan Y.Spatial Heterogeneity in the Tumor Microenvironment..Cold Spring Harb Perspect Med2016;6: PMCID:PMC4968167

[86] Bakhshinyan D,Qazi MA.Introduction to Cancer Stem Cells: Past, Present, and Future..Methods Mol Biol2018;1692:1-16

[87] Garcia-Mayea Y,Masson F,ME LL.Insights into new mechanisms and models of cancer stem cell multidrug resistance..Semin Cancer Biol2020;60:166-80

[88] Koren E.The bad seed: Cancer stem cells in tumor development and resistance..Drug Resist Updat2016;28:1-12

[89] Wang YH.Harnessing the apoptotic programs in cancer stem-like cells..EMBO Rep2015;16:1084-98 PMCID:PMC4576979

[90] Singh SK,Terasaki M,Hawkins C,Dirks PB.Identification of a cancer stem cell in human brain tumors..Cancer Res2003;63:5821-8

[91] Cho Y.Cancer Stem Cells as a Potential Target to Overcome Multidrug Resistance..Front Oncol2020;10:764 PMCID:PMC7280434

[92] Gupta PB,Weinberg RA.Cancer stem cells: mirage or reality?.Nat Med2009;15:1010-2

[93] Bu Y.The origin of cancer stem cells..Front Biosci (Schol Ed)2012;4:819-30

[94] Hangauer MJ,Ryan MJ.Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition..Nature2017;551:247-50 PMCID:PMC5933935

[95] Boesch M,Wolf D,Sopper S.Harnessing the DNA Dye-triggered Side Population Phenotype to Detect and Purify Cancer Stem Cells from Biological Samples..J Vis Exp2017; PMCID:PMC5607907

[96] Dean M,Bates S.Tumour stem cells and drug resistance..Nat Rev Cancer2005;5:275-84

[97] McIntosh K,Tiwari AK.Tackling multidrug resistance mediated by efflux transporters in tumor-initiating cells..Expert Opin Drug Metab Toxicol2016;12:633-44

[98] Begicevic RR.ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance..Int J Mol Sci2017;18:2362 PMCID:PMC5713331

[99] Hashida S,Shien K.Acquisition of cancer stem cell-like properties in non-small cell lung cancer with acquired resistance to afatinib..Cancer Sci2015;106:1377-84 PMCID:PMC4638008

[100] Eyre R,Stemke-Hale K,Tyson-Capper A.Reversing paclitaxel resistance in ovarian cancer cells via inhibition of the ABCB1 expressing side population..Tumour Biol2014;35:9879-92

[101] Kobayashi Y,Hosonuma S.Side population is increased in paclitaxel-resistant ovarian cancer cell lines regardless of resistance to cisplatin..Gynecol Oncol2011;121:390-4

[102] Yamamoto M,Togashi K.AS602801 Sensitizes Ovarian Cancer Stem Cells to Paclitaxel by Down-regulating MDR1..Anticancer Res2019;39:609-17

[103] Emmink BL,Vries RG.Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan..Gastroenterology2011;141:269-78

[104] Goto S,Li TS.Enhanced Expression of ABCB1 and Nrf2 in CD133-Positive Cancer Stem Cells Associates with Doxorubicin Resistance..Stem Cells Int2020;2020:8868849 PMCID:PMC7441449

[105] Liu YS,Tseng KC,Chen SJ.Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer..Biomed Pharmacother2013;67:791-9

[106] Zhou J,Liu T.Persistence of side population cells with high drug efflux capacity in pancreatic cancer..World J Gastroenterol2008;14:925-30 PMCID:PMC2687061

[107] Naik PP,Panda PK.Autophagy regulates cisplatin-induced stemness and chemoresistance via the upregulation of CD44, ABCB1 and ADAM17 in oral squamous cell carcinoma..Cell Prolif2018;51:e12411 PMCID:PMC6528880

[108] Nakai E,Yawata T.Enhanced MDR1 expression and chemoresistance of cancer stem cells derived from glioblastoma..Cancer Invest2009;27:901-8

[109] Shervington A.Expression of multidrug resistance genes in normal and cancer stem cells..Cancer Invest2008;26:535-42

[110] Sadeghi MR,Soozangar N.Nrf2/P-glycoprotein axis is associated with clinicopathological characteristics in colorectal cancer..Biomed Pharmacother2018;104:458-64

[111] Marques DS,Boyle RT,Trindade GS.Relationships between multidrug resistance (MDR) and stem cell markers in human chronic myeloid leukemia cell lines..Leuk Res2010;34:757-62

[112] Bourguignon LY,Xia W.Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells..J Biol Chem2008;283:17635-51 PMCID:PMC2427357

[113] Deng JJ,Xu XM,Tao WP,Ge W.Twist mediates an aggressive phenotype in human colorectal cancer cells..Int J Oncol2016;48:1117-24

[114] Riganti C,Caldera V.Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/beta-catenin pathway..Neuro Oncol2013;15:1502-17 PMCID:PMC3813413

[115] Angelastro JM.Overexpression of CD133 promotes drug resistance in C6 glioma cells..Mol Cancer Res2010;8:1105-15 PMCID:PMC2923683

[116] White MD,Bissiere S.Instructions for Assembling the Early Mammalian Embryo..Dev Cell2018;45:667-79

[117] Chazaud C.Lineage specification in the mouse preimplantation embryo..Development2016;143:1063-74

[118] Zhang HT.Symmetry Breaking in the Mammalian Embryo..Annu Rev Cell Dev Biol2018;34:405-26

[119] Li P.Communication codes in developmental signaling pathways..Development2019;146: PMCID:PMC6602343

[120] Siebel C.Notch Signaling in Development, Tissue Homeostasis, and Disease..Physiol Rev2017;97:1235-94

[121] Groot AJ.The role of Adams in Notch signaling..Adv Exp Med Biol2012;727:15-36 PMCID:PMC4050497

[122] Kopan R,Weintraub H.Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain..Proc Natl Acad Sci U S A1996;93:1683-8 PMCID:PMC40002

[123] Lal M.Regulated intramembrane proteolysis: signaling pathways and biological functions..Physiology (Bethesda)2011;26:34-44

[124] Schroeter EH,Kopan R.Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain..Nature1998;393:382-6

[125] De Strooper B.Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex..Neuron2003;38:9-12

[126] Zhang X,Xu H.The gamma-secretase complex: from structure to function..Front Cell Neurosci2014;8:427 PMCID:PMC4263104

[127] Andersson ER,Lendahl U.Notch signaling: simplicity in design, versatility in function..Development2011;138:3593-612

[128] Ayaz F.Non-canonical notch signaling in cancer and immunity..Front Oncol2014;4:345 PMCID:PMC4255497

[129] Andersen P,Shenje LT.Non-canonical Notch signaling: emerging role and mechanism..Trends Cell Biol2012;22:257-65 PMCID:PMC3348455

[130] Park JT,Trope CG,Shih Ie M.Notch3 overexpression is related to the recurrence of ovarian cancer and confers resistance to carboplatin..Am J Pathol2010;177:1087-94 PMCID:PMC2928943

[131] Wu WR,Shi XD.Notch1 is overexpressed in human intrahepatic cholangiocarcinoma and is associated with its proliferation, invasiveness and sensitivity to 5-fluorouracil in vitro..Oncol Rep2014;31:2515-24

[132] Harbuzariu A,Daley-Brown DS.Leptin-Notch signaling axis is involved in pancreatic cancer progression..Oncotarget2017;8:7740-52 PMCID:PMC5352357

[133] Steg AD,Goodman B.Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer..Clin Cancer Res2011;17:5674-85 PMCID:PMC3166981

[134] Zou W,Hua W,Cai G.Caveolin-1 mediates chemoresistance in cisplatin-resistant ovarian cancer cells by targeting apoptosis through the Notch-1/Akt/NF-kappaB pathway..Oncol Rep2015;34:3256-63

[135] Zhang C,Zhang J.Caveolin-1 promotes invasion and metastasis by upregulating Pofut1 expression in mouse hepatocellular carcinoma..Cell Death Dis2019;10:477 PMCID:PMC6572835

[136] Kapoor A,Wang BJ.Caveolin-1 regulates gamma-secretase-mediated AbetaPP processing by modulating spatial distribution of gamma-secretase in membrane..J Alzheimers Dis2010;22:423-42

[137] Antonio-Andres G,Tirado-Rodriguez B,Torres Nava J,Huerta-Yepez S.Role of Yin Yang-1 (YY1) in the transcription regulation of the multi-drug resistance (MDR1) gene..Leuk Lymphoma2018;59:2628-38

[138] Bentires-Alj M,Fillet M.NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells..Oncogene2003;22:90-7

[139] Thévenod F,Katsen AD.Up-regulation of multidrug resistance P-glycoprotein via nuclear factor-kappaB activation protects kidney proximal tubule cells from cadmium- and reactive oxygen species-induced apoptosis..J Biol Chem2000;275:1887-96

[140] Yamada T,Hayashi R.Suppression of intestinal polyposis in Mdr1-deficient ApcMin/+ mice..Cancer Res2003;63:895-901

[141] Comerford KM,Karhausen J,Montalto MC.Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene..Cancer Res2002;62:3387-94

[142] Lee JJ,Parks S.Secretion and localized transcription suggest a role in positional signaling for products of the segmentation gene hedgehog..Cell1992;71:33-50

[143] Nusslein-Volhard C.Mutations affecting segment number and polarity in Drosophila..Nature1980;287:795-801

[144] Riddle RD,Laufer E.Sonic hedgehog mediates the polarizing activity of the ZPA..Cell1993;75:1401-16

[145] Ingham PW.Hedgehog signaling in animal development: paradigms and principles..Genes Dev2001;15:3059-87

[146] Johnson RL,Laufer E.Sonic hedgehog: a key mediator of anterior-posterior patterning of the limb and dorso-ventral patterning of axial embryonic structures..Biochem Soc Trans1994;22:569-74

[147] Stone DM,Armanini M.The tumour-suppressor gene patched encodes a candidate receptor for Sonic hedgehog..Nature1996;384:129-34

[148] Qi X,Coutavas E,Li X.Structures of human Patched and its complex with native palmitoylated sonic hedgehog..Nature2018;560:128-32 PMCID:PMC6341490

[149] Sommer A.Smoothening out the patches..Science2018;362:26-7 PMCID:PMC6421564

[150] Chen Y,Xie L,Jin T.Dual Phosphorylation of suppressor of fused (Sufu) by PKA and GSK3beta regulates its stability and localization in the primary cilium..J Biol Chem2011;286:13502-11 PMCID:PMC3075696

[151] Lee RT,Ingham PW.Hedgehog signalling..Development2016;143:367-72

[152] Pak E.Hedgehog Signal Transduction: Key Players, Oncogenic Drivers, and Cancer Therapy..Dev Cell2016;38:333-44 PMCID:PMC5017307

[153] Merchant M,Ultsch M.Suppressor of fused regulates Gli activity through a dual binding mechanism..Mol Cell Biol2004;24:8627-41 PMCID:PMC516763

[154] Kise Y,Teglund S.Sufu recruits GSK3beta for efficient processing of Gli3..Biochem Biophys Res Commun2009;387:569-74

[155] Niewiadomski P,Ahrends R.Gli protein activity is controlled by multisite phosphorylation in vertebrate Hedgehog signaling..Cell Rep2014;6:168-81 PMCID:PMC3915062

[156] Antonucci L,D’Amico D.Mitogen-activated kinase kinase kinase 1 inhibits hedgehog signaling and medulloblastoma growth through GLI1 phosphorylation..Int J Oncol2019;54:505-14 PMCID:PMC6317670

[157] Shi Q,Li S,Chen Y.Hedgehog-induced phosphorylation by CK1 sustains the activity of Ci/Gli activator..Proc Natl Acad Sci U S A2014;111:E5651-60 PMCID:PMC4284548

[158] Han Y,Cho YS,Wu J,Jiang J.Phosphorylation of Ci/Gli by Fused Family Kinases Promotes Hedgehog Signaling..Dev Cell2019;50:610-26 e4 PMCID:PMC6736714

[159] Sims-Mourtada J,Ajani J.Sonic Hedgehog promotes multiple drug resistance by regulation of drug transport..Oncogene2007;26:5674-9

[160] Queiroz KC,Fuhler GM.Hedgehog signaling maintains chemoresistance in myeloid leukemic cells..Oncogene2010;29:6314-22

[161] Po A,Catanzaro G.Hedgehog-GLI signalling promotes chemoresistance through the regulation of ABC transporters in colorectal cancer cells..Sci Rep2020;10:13988 PMCID:PMC7438531

[162] Chen Y,Teng NN.Hedgehog signaling regulates drug sensitivity by targeting ABC transporters ABCB1 and ABCG2 in epithelial ovarian cancer..Mol Carcinog2014;53:625-34

[163] Chen YJ,Chen SH.Small-molecule synthetic compound norcantharidin reverses multi-drug resistance by regulating Sonic hedgehog signaling in human breast cancer cells..PLoS One2012;7:e37006 PMCID:PMC3352857

[164] Lu YL,Feng C.Co-delivery of Cyclopamine and Doxorubicin Mediated by Bovine Serum Albumin Nanoparticles Reverses Doxorubicin Resistance in Breast Cancer by Down-regulating P-glycoprotein Expression..J Cancer2019;10:2357-68 PMCID:PMC6584414

[165] Zhang Y,Pomper MG.Hedgehog pathway inhibitor HhAntag691 is a potent inhibitor of ABCG2/BCRP and ABCB1/Pgp..Neoplasia2009;11:96-101 PMCID:PMC2606123

[166] Lee MJ,Villavicencio EH.Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model..Proc Natl Acad Sci U S A2012;109:7859-64 PMCID:PMC3356655

[167] Zhou H,Wei W.B4GALT family mediates the multidrug resistance of human leukemia cells by regulating the hedgehog pathway and the expression of p-glycoprotein and multidrug resistance-associated protein 1..Cell Death Dis2013;4:e654 PMCID:PMC3698553

[168] Zhou H,Liu C.B4GALT1 gene knockdown inhibits the hedgehog pathway and reverses multidrug resistance in the human leukemia K562/adriamycin-resistant cell line..IUBMB Life2012;64:889-900

[169] Munoz JL,Ramkissoon SH,Greco SJ.Temozolomide resistance in glioblastoma occurs by miRNA-9-targeted PTCH1, independent of sonic hedgehog level..Oncotarget2015;6:1190-201 PMCID:PMC4359226

[170] Liu Z,He J.A critical role of autocrine sonic hedgehog signaling in human CD138+ myeloma cell survival and drug resistance..Blood2014;124:2061-71 PMCID:PMC4186536

[171] Clevers H.Wnt/beta-catenin signaling in development and disease..Cell2006;127:469-80

[172] Petersen CP.Wnt signaling and the polarity of the primary body axis..Cell2009;139:1056-68

[173] Steinhart Z.Wnt signaling in development and tissue homeostasis..Development2018;145:

[174] Komiya Y.Wnt signal transduction pathways..Organogenesis2008;4:68-75 PMCID:PMC2634250

[175] MacDonald BT,He X.Wnt/beta-catenin signaling: components, mechanisms, and diseases..Dev Cell2009;17:9-26 PMCID:PMC2861485

[176] Wiese KE,van Amerongen R.Wnt signalling: conquering complexity..Development2018;145:dev165902

[177] Nusse R.Wnt/beta-Catenin Signaling, Disease, and Emerging Therapeutic Modalities..Cell2017;169:985-99

[178] Anastas JN.WNT signalling pathways as therapeutic targets in cancer..Nat Rev Cancer2013;13:11-26

[179] Mikels AJ.Wnts as ligands: processing, secretion and reception..Oncogene2006;25:7461-8

[180] MacDonald BT.Frizzled and LRP5/6 receptors for Wnt/beta-catenin signaling..Cold Spring Harb Perspect Biol2012;4:a007880 PMCID:PMC3504444

[181] Cruciat CM.Secreted and transmembrane wnt inhibitors and activators..Cold Spring Harb Perspect Biol2013;5:a015081 PMCID:PMC3578365

[182] Kawano Y.Secreted antagonists of the Wnt signalling pathway..J Cell Sci2003;116:2627-34

[183] de Lau W,Gros P.The R-spondin/Lgr5/Rnf43 module: regulator of Wnt signal strength..Genes Dev2014;28:305-16 PMCID:PMC3937510

[184] Morgan RG,Williams AC.Targeting LGR5 in Colorectal Cancer: therapeutic gold or too plastic?.Br J Cancer2018;118:1410-8 PMCID:PMC5988707

[185] de Sousa e Melo F,Harnoss JM.A distinct role for Lgr5(+) stem cells in primary and metastatic colon cancer..Nature2017;543:676-80

[186] Shimokawa M,Nishikori S.Visualization and targeting of LGR5(+) human colon cancer stem cells..Nature2017;545:187-92

[187] Stamos JL.The beta-catenin destruction complex..Cold Spring Harb Perspect Biol2013;5:a007898 PMCID:PMC3579403

[188] Tamai K,Liu C.A mechanism for Wnt coreceptor activation..Mol Cell2004;13:149-56

[189] Zeng X,Doble B.A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation..Nature2005;438:873-7 PMCID:PMC2100418

[190] Behrens J,Kuhl M.Functional interaction of beta-catenin with the transcription factor LEF-1..Nature1996;382:638-42

[191] Brunner E,Schweizer L.pangolin encodes a Lef-1 homologue that acts downstream of Armadillo to transduce the Wingless signal in Drosophila..Nature1997;385:829-33

[192] Molenaar M,Oosterwegel M.XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos..Cell1996;86:391-9

[193] Gao C.Dishevelled: The hub of Wnt signaling..Cell Signal2010;22:717-27

[194] Fang M,Blauwkamp T,Campbell N.C-terminal-binding protein directly activates and represses Wnt transcriptional targets in Drosophila..EMBO J2006;25:2735-45 PMCID:PMC1500853

[195] Levanon D,Bernstein Y.Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors..Proc Natl Acad Sci U S A1998;95:11590-5 PMCID:PMC21685

[196] Brack AS,Hanifi J.BCL9 is an essential component of canonical Wnt signaling that mediates the differentiation of myogenic progenitors during muscle regeneration..Dev Biol2009;335:93-105 PMCID:PMC3259687

[197] Hecht A,Stemmler MP,Kemler R.The p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates..EMBO J2000;19:1839-50 PMCID:PMC302022

[198] Schwab KR,Hartman HA.Pygo1 and Pygo2 roles in Wnt signaling in mammalian kidney development..BMC Biol2007;5:15 PMCID:PMC1858683

[199] He TC,Rago C.Identification of c-MYC as a target of the APC pathway..Science1998;281:1509-12

[200] Shtutman M,Simcha I.The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway..Proc Natl Acad Sci U S A1999;96:5522-7 PMCID:PMC21892

[201] Tetsu O.Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells..Nature1999;398:422-6

[202] Yamada T,Naishiro Y.Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis..Cancer Res2000;60:4761-6

[203] Nusse R.Wnt Target Genes. In;2020;

[204] Powell SM,Beazer-Barclay Y.APC mutations occur early during colorectal tumorigenesis..Nature1992;359:235-7

[205] Kinzler KW.Lessons from hereditary colorectal cancer..Cell1996;87:159-70

[206] Polakis P.The adenomatous polyposis coli (APC) tumor suppressor..Biochim Biophys Acta1997;1332:F127-47

[207] Klaus A.Wnt signalling and its impact on development and cancer..Nat Rev Cancer2008;8:387-98

[208] Polakis P.Wnt signaling in cancer..Cold Spring Harb Perspect Biol2012;4: PMCID:PMC3331705

[209] Zhan T,Boutros M.Wnt signaling in cancer..Oncogene2017;36:1461-73 PMCID:PMC5357762

[210] Cerami E,Dogrusoz U.The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data..Cancer Discov2012;2:401-4 PMCID:PMC3956037

[211] Gao J,Dogrusoz U.Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal..Sci Signal2013;6:pl1 PMCID:PMC4160307

[212] Clevers H,Nusse R.Stem cell signaling. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control..Science2014;346:1248012

[213] Ghandadi M,Mohammadi H,Khodashenas S.Wnt-beta-catenin Signaling Pathway, the Achilles’ Heels of Cancer Multidrug Resistance..Curr Pharm Des2019;25:4192-207

[214] Esteller M.CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future..Oncogene2002;21:5427-40

[215] Kulis M.DNA methylation and cancer..Adv Genet2010;70:27-56

[216] Cho NY,Choi M.Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features..J Pathol2007;211:269-77

[217] Enokida H,Urakami S.Multigene methylation analysis for detection and staging of prostate cancer..Clin Cancer Res2005;11:6582-8

[218] Lin Q,Ma K.RASSF1A, APC, ESR1, ABCB1 and HOXC9, but not p16INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage I non-small cell lung cancer in China..J Cancer Res Clin Oncol2009;135:1675-84

[219] Yegnasubramanian S,Gonzalgo ML.Hypermethylation of CpG islands in primary and metastatic human prostate cancer..Cancer Res2004;64:1975-86

[220] Wang H,Hu R.Methylation of SFRP5 is related to multidrug resistance in leukemia cells..Cancer Gene Ther2014;21:83-9

[221] Narita T,Choudhary C.Functions and mechanisms of non-histone protein acetylation..Nat Rev Mol Cell Biol2019;20:156-74

[222] Kuo MH.Roles of histone acetyltransferases and deacetylases in gene regulation..Bioessays1998;20:615-26

[223] Wielenga VJ,Korinek V.Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway..Am J Pathol1999;154:515-23 PMCID:PMC1850011

[224] Bourguignon LY,Wong G.Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells..J Biol Chem2009;284:2657-71 PMCID:PMC2631959

[225] Cech TR.The noncoding RNA revolution-trashing old rules to forge new ones..Cell2014;157:77-94

[226] Slack FJ.The Role of Non-coding RNAs in Oncology..Cell2019;179:1033-55 PMCID:PMC7347159

[227] Bartel DP.Metazoan MicroRNAs..Cell2018;173:20-51 PMCID:PMC6091663

[228] Djuranovic S,Green R.miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay..Science2012;336:237-40 PMCID:PMC3971879

[229] Kopp F.Functional Classification and Experimental Dissection of Long Noncoding RNAs..Cell2018;172:393-407 PMCID:PMC5978744

[230] Quinn JJ.Unique features of long non-coding RNA biogenesis and function..Nat Rev Genet2016;17:47-62

[231] Ma Y,Wang F.Long non-coding RNA CCAL regulates colorectal cancer progression by activating Wnt/beta-catenin signalling pathway via suppression of activator protein 2alpha..Gut2016;65:1494-504

[232] Chen Z,Jiang D.The lncRNA-GAS5/miR-221-3p/DKK2 Axis Modulates ABCB1-Mediated Adriamycin Resistance of Breast Cancer via the Wnt/beta-Catenin Signaling Pathway..Mol Ther Nucleic Acids2020;19:1434-48 PMCID:PMC7056627

[233] Hung TH,Cheng CY.Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/beta-catenin pathway..Oncotarget2014;5:12273-90 PMCID:PMC4322984

[234] Grivennikov SI,Karin M.Immunity, inflammation, and cancer..Cell2010;140:883-99 PMCID:PMC2866629

[235] Yamamoto K,Ueda N.Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells..J Biol Chem1995;270:31315-20

[236] Zhou G.NF-kappaB-mediated induction of mdr1b expression by insulin in rat hepatoma cells..J Biol Chem1997;272:15174-83

[237] Haertel-Wiesmann M,Fantl WJ.Regulation of cyclooxygenase-2 and periostin by Wnt-3 in mouse mammary epithelial cells..J Biol Chem2000;275:32046-51

[238] Howe LR,Chung WJ,Brown AM.Transcriptional activation of cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells..Cancer Res1999;59:1572-7

[239] Castellone MD,Williams BO,Gutkind JS.Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis..Science2005;310:1504-10

[240] Lim K,Xu L,Demetris AJ.Cyclooxygenase-2-derived prostaglandin E2 activates beta-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids..Cancer Res2008;68:553-60

[241] Liu XH,Weinstein BM,Yao S.Prostaglandin E2 modulates components of the Wnt signaling system in bone and prostate cancer cells..Biochem Biophys Res Commun2010;394:715-20

[242] Nunez F,Cruzat F,De Ferrari GV.Wnt/beta-catenin signaling enhances cyclooxygenase-2 (COX2) transcriptional activity in gastric cancer cells..PLoS One2011;6:e18562 PMCID:PMC3071840

[243] Wu M,Li C.Aberrantly activated Cox-2 and Wnt signaling interact to maintain cancer stem cells in glioblastoma..Oncotarget2017;8:82217-30 PMCID:PMC5669884

[244] Gala MK.Molecular pathways: aspirin and Wnt signaling-a molecularly targeted approach to cancer prevention and treatment..Clin Cancer Res2015;21:1543-8 PMCID:PMC4383688

[245] Vallee A,Vallee JN.Targeting the Canonical WNT/beta-Catenin Pathway in Cancer Treatment Using Non-Steroidal Anti-Inflammatory Drugs..Cells2019;8:726 PMCID:PMC6679009

[246] Zimmerman ZF,Chien AJ.Targeting Wnt pathways in disease..Cold Spring Harb Perspect Biol2012;4: PMCID:PMC3536347

[247] Martinez-Hackert E,Holien T.Receptor binding competition: A paradigm for regulating TGF-beta family action..Cytokine Growth Factor Rev2021;57:39-54 PMCID:PMC7897244

[248] Wu MY.Tgf-beta superfamily signaling in embryonic development and homeostasis..Dev Cell2009;16:329-43

[249] Smith AL,Ford HL.Molecular pathways: targeting the TGF-beta pathway for cancer therapy..Clin Cancer Res2012;18:4514-21

[250] Tzavlaki K.TGF-beta Signaling..Biomolecules2020;10:487 PMCID:PMC7175140

[251] Daly AC,Hill CS.Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth..Mol Cell Biol2008;28:6889-902 PMCID:PMC2573298

[252] Liu IM,Knouse KA,Derynck R.TGFbeta-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGFbeta switch..EMBO J2009;28:88-98 PMCID:PMC2634733

[253] Schmierer B,Bates PA.Mathematical modeling identifies Smad nucleocytoplasmic shuttling as a dynamic signal-interpreting system..Proc Natl Acad Sci U S A2008;105:6608-13 PMCID:PMC2373357

[254] Derynck R,Akhurst RJ.TGFbeta biology in cancer progression and immunotherapy..Nat Rev Clin Oncol2021;18:9-34

[255] Zhang X,Batist G.Transforming growth factor beta 1 promotes spontaneous transformation of cultured rat liver epithelial cells..Cancer Res1994;54:6122-8

[256] Tomiyasu H,Goto-Koshino Y.Regulation of expression of ABCB1 and LRP genes by mitogen-activated protein kinase/extracellular signal-regulated kinase pathway and its role in generation of side population cells in canine lymphoma cell lines..Leuk Lymphoma2013;54:1309-15

[257] Sun W,Chen P.MicroRNA-10a silencing reverses cisplatin resistance in the A549/cisplatin human lung cancer cell line via the transforming growth factor-beta/Smad2/STAT3/STAT5 pathway..Mol Med Rep2015;11:3854-9

[258] Ornitz DM.The Fibroblast Growth Factor signaling pathway..Wiley Interdiscip Rev Dev Biol2015;4:215-66 PMCID:PMC4393358

[259] Touat M,Postel-Vinay S,Soria JC.Targeting FGFR Signaling in Cancer..Clin Cancer Res2015;21:2684-94

[260] Kato T,Nakane K.ETS1 promotes chemoresistance and invasion of paclitaxel-resistant, hormone-refractory PC3 prostate cancer cells by up-regulating MDR1 and MMP9 expression..Biochem Biophys Res Commun2012;417:966-71

[261] Wang J,Luo T,Chen S.Involvement of V-Ets erythroblastosis virus E26 oncogene homolog 2 in regulation of transcription activity of MDR1 gene..Acta Biochim Biophys Sin (Shanghai)2012;44:752-8

[262] Gan Y,Au JL.Expression of basic fibroblast growth factor correlates with resistance to paclitaxel in human patient tumors..Pharm Res2006;23:1324-31

[263] Davis JR.Hippo signalling during development..Development2019;146:dev167106 PMCID:PMC7100553

[264] Liu AM,Jiang X,Luk JM.Regulators of mammalian Hippo pathway in cancer..Biochim Biophys Acta2012;1826:357-64

[265] Zhao B,Guan KL.Hippo signaling at a glance..J Cell Sci2010;123:4001-6 PMCID:PMC2987436

[266] Suemura S,Myojin Y.CRISPR Loss-of-Function Screen Identifies the Hippo Signaling Pathway as the Mediator of Regorafenib Efficacy in Hepatocellular Carcinoma..Cancers (Basel)2019;11:1362 PMCID:PMC6770429

[267] Nguyen CDK.YAP/TAZ Signaling and Resistance to Cancer Therapy..Trends Cancer2019;5:283-96 PMCID:PMC6557283

[268] Xia Y,Yu C,Fan HY.YAP/TEAD co-activator regulated pluripotency and chemoresistance in ovarian cancer initiated cells..PLoS One2014;9:e109575 PMCID:PMC4219672

[269] Bhullar J.YBX1 expression and function in early hematopoiesis and leukemic cells..Immunogenetics2011;63:337-50

[270] Evans MK,Xu B.Ybx1 fine-tunes PRC2 activities to control embryonic brain development..Nat Commun2020;11:4060 PMCID:PMC7426271

[271] Liu Z,Li X.Overexpression of YBX1 Promotes Pancreatic Ductal Adenocarcinoma Growth via the GSK3B/Cyclin D1/Cyclin E1 Pathway..Mol Ther Oncolytics2020;17:21-30 PMCID:PMC7150436

[272] Shibata T,Hattori S.Y-box binding protein YBX1 and its correlated genes as biomarkers for poor outcomes in patients with breast cancer..Oncotarget2018;9:37216-28 PMCID:PMC6324687

[273] Xu L,Wu L.YBX1 promotes tumor growth by elevating glycolysis in human bladder cancer..Oncotarget2017;8:65946-56 PMCID:PMC5630384

[274] Hartley AV,Mundade R.PRMT5-mediated methylation of YBX1 regulates NF-kappaB activity in colorectal cancer..Sci Rep2020;10:15934 PMCID:PMC7522246

[275] Jurchott K,Krech T.Identification of Y-box binding protein 1 as a core regulator of MEK/ERK pathway-dependent gene signatures in colorectal cancer cells..PLoS Genet2010;6:e1001231 PMCID:PMC2996331

[276] Zhao P,Wu Y.Long noncoding RNA SNHG6 promotes carcinogenesis by enhancing YBX1-mediated translation of HIF1alpha in clear cell renal cell carcinoma..FASEB J2021;35:e21160

[277] Kuwano M,Watari K.Oncogenic Y-box binding protein-1 as an effective therapeutic target in drug-resistant cancer..Cancer Sci2019;110:1536-43 PMCID:PMC6500994

[278] Kotake Y,Tahara K,Naemura M.Y-box Binding Protein 1 Is Involved in Regulating the G2/M Phase of the Cell Cycle..Anticancer Res2017;37:1603-8

[279] Martin M,Wang B.Novel Serine 176 Phosphorylation of YBX1 Activates NF-kappaB in Colon Cancer..J Biol Chem2017;292:3433-44 PMCID:PMC5336175

[280] Dongre A.New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer..Nat Rev Mol Cell Biol2019;20:69-84

[281] Lamouille S,Derynck R.Molecular mechanisms of epithelial-mesenchymal transition..Nat Rev Mol Cell Biol2014;15:178-96 PMCID:PMC4240281

[282] Murray SA.Snail1 gene function during early embryo patterning in mice..Cell Cycle2006;5:2566-70

[283] De Craene B,Berx G.Unraveling signalling cascades for the Snail family of transcription factors..Cell Signal2005;17:535-47

[284] Vega S,Ocana OH,Fabregat I.Snail blocks the cell cycle and confers resistance to cell death..Genes Dev2004;18:1131-43 PMCID:PMC415638

[285] Lin Y,Zhou BP.Epigenetic regulation of EMT: the Snail story..Curr Pharm Des2014;20:1698-705 PMCID:PMC4005722

[286] Zhao XY,Wang XB.Inhibition of Snail Family Transcriptional Repressor 2 (SNAI2) Enhances Multidrug Resistance of Hepatocellular Carcinoma Cells..PLoS One2016;11:e0164752 PMCID:PMC5070735

[287] Wang H,Wei W.Regulation of ATP-binding cassette subfamily B member 1 by Snail contributes to chemoresistance in colorectal cancer..Cancer Sci2020;111:84-97 PMCID:PMC6942434

[288] Reynolds N,Hendrich B.Transcriptional repressors: multifaceted regulators of gene expression..Development2013;140:505-12

[289] Gage PJ,Camper SA.The bicoid-related Pitx gene family in development..Mamm Genome1999;10:197-200

[290] Gage PJ.Pituitary homeobox 2, a novel member of the bicoid-related family of homeobox genes, is a potential regulator of anterior structure formation..Hum Mol Genet1997;6:457-64

[291] Lamba P,Bernard DJ.Novel forms of Paired-like homeodomain transcription factor 2 (PITX2): generation by alternative translation initiation and mRNA splicing..BMC Mol Biol2008;9:31 PMCID:PMC2330153

[292] Cox CJ,McWilliams B.Differential regulation of gene expression by PITX2 isoforms..J Biol Chem2002;277:25001-10

[293] Hernandez-Torres F,Aranega AE.Expression patterns and immunohistochemical localization of PITX2B transcription factor in the developing mouse heart..Int J Dev Biol2015;59:247-54

[294] Wei Q.Pitx2a expression alters actin-myosin cytoskeleton and migration of HeLa cells through Rho GTPase signaling..Mol Biol Cell2002;13:683-97 PMCID:PMC65659

[295] Ganga M,Cox CJ.PITX2 isoform-specific regulation of atrial natriuretic factor expression: synergism and repression with Nkx2.5..J Biol Chem2003;278:22437-45

[296] Semina EV,Murray JC.Isolation of a new homeobox gene belonging to the Pitx/Rieg family: expression during lens development and mapping to the aphakia region on mouse chromosome 19..Hum Mol Genet1997;6:2109-16

[297] Lin CR,O’Connell S.Pitx2 regulates lung asymmetry, cardiac positioning and pituitary and tooth morphogenesis..Nature1999;401:279-82

[298] Szeto DP,Ryan AK.Role of the Bicoid-related homeodomain factor Pitx1 in specifying hindlimb morphogenesis and pituitary development..Genes Dev1999;13:484-94 PMCID:PMC316471

[299] Tao G,Morikawa Y.Pitx2 promotes heart repair by activating the antioxidant response after cardiac injury..Nature2016;534:119-23 PMCID:PMC4999251

[300] Charles MA,Hjalt TA,Camper SA.PITX genes are required for cell survival and Lhx3 activation..Mol Endocrinol2005;19:1893-903

[301] Hjalt TA.Current molecular understanding of Axenfeld-Rieger syndrome..Expert Rev Mol Med2005;7:1-17

[302] Seifi M.Axenfeld-Rieger syndrome..Clin Genet2018;93:1123-30

[303] Kolfschoten IG,Berns K.A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity..Cell2005;121:849-58

[304] Mudie S,Batie M.PITX1, a specificity determinant in the HIF-1alpha-mediated transcriptional response to hypoxia..Cell Cycle2014;13:3878-91 PMCID:PMC4614811

[305] Qi DL,Fujisaki C.Identification of PITX1 as a TERT suppressor gene located on human chromosome 5..Mol Cell Biol2011;31:1624-36 PMCID:PMC3126332

[306] Arakawa H,Zhadanov AB.Identification and characterization of the ARP1 gene, a target for the human acute leukemia ALL1 gene..Proc Natl Acad Sci U S A1998;95:4573-8 PMCID:PMC22531

[307] Toyota M,Toyota MO,Willman CL.Methylation profiling in acute myeloid leukemia..Blood2001;97:2823-9

[308] Kioussi C,Baek SH.Identification of a Wnt/Dvl/beta-Catenin --> Pitx2 pathway mediating cell-type-specific proliferation during development..Cell2002;111:673-85

[309] Vadlamudi U,Ganga M.PITX2, beta-catenin and LEF-1 interact to synergistically regulate the LEF-1 promoter..J Cell Sci2005;118:1129-37

[310] Liu Y,Zhu GZ.Cyclin A1 is a transcriptional target of PITX2 and overexpressed in papillary thyroid carcinoma..Mol Cell Biochem2013;384:221-7

[311] Huang Y,Fan J,Zhu GZ.Pituitary homeobox 2 (PITX2) promotes thyroid carcinogenesis by activation of cyclin D2..Cell Cycle2010;9:1333-41

[312] Baek SH,Briata P.Regulated subset of G1 growth-control genes in response to derepression by the Wnt pathway..Proc Natl Acad Sci U S A2003;100:3245-50 PMCID:PMC152277

[313] Hirose H,Mimori K.The significance of PITX2 overexpression in human colorectal cancer..Ann Surg Oncol2011;18:3005-12

[314] Fung FK,Liu VW,Cheung AN.Increased Expression of PITX2 Transcription Factor Contributes to Ovarian Cancer Progression..PLoS One2012;7:e37076 PMCID:PMC3352869

[315] Basu M,Ray U,Chatterjee U.Invasion of ovarian cancer cells is induced by PITX2-mediated activation of TGF-beta and Activin-A..Mol Cancer2015;14:162 PMCID:PMC4546816

[316] Pillai SG,Siddappa CM.Paired-like Homeodomain Transcription factor 2 expression by breast cancer bone marrow disseminated tumor cells is associated with early recurrent disease development..Breast Cancer Res Treat2015;153:507-17 PMCID:PMC4589549

[317] Dietrich D,Liebenberg V,Kristiansen G.DNA methylation of the homeobox genes PITX2 and SHOX2 predicts outcome in non-small-cell lung cancer patients..Diagn Mol Pathol2012;21:93-104

[318] Lopez JI,Martin A.A DNA hypermethylation profile reveals new potential biomarkers for the evaluation of prognosis in urothelial bladder cancer..APMIS2017;125:787-96

[319] Nimmrich I,Meijer-van Gelder ME.DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients..Breast Cancer Res Treat2008;111:429-37

[320] Dietrich D,Banez LL.Development and clinical validation of a real-time PCR assay for PITX2 DNA methylation to predict prostate-specific antigen recurrence in prostate cancer patients following radical prostatectomy..J Mol Diagn2013;15:270-9 PMCID:PMC5707187

[321] Zhang JX,Xu Y.Downregulation of MicroRNA-644a Promotes Esophageal Squamous Cell Carcinoma Aggressiveness and Stem Cell-like Phenotype via Dysregulation of PITX2..Clin Cancer Res2017;23:298-310

[322] Lozano-Velasco E,Esteban FJ.A Pitx2-MicroRNA Pathway Modulates Cell Proliferation in Myoblasts and Skeletal-Muscle Satellite Cells and Promotes Their Commitment to a Myogenic Cell Fate..Mol Cell Biol2015;35:2892-909 PMCID:PMC4525317

[323] Hilton T,Kioussi C.Pitx2-dependent occupancy by histone deacetylases is associated with T-box gene regulation in mammalian abdominal tissue..J Biol Chem2010;285:11129-42 PMCID:PMC2856990

[324] Mikeska T,Do H.DNA methylation biomarkers in cancer: progress towards clinical implementation..Expert Rev Mol Diagn2012;12:473-87

[325] Amendt BA,Russo AF.Multifunctional role of the Pitx2 homeodomain protein C-terminal tail..Mol Cell Biol1999;19:7001-10 PMCID:PMC84695

[326] Kozlowski K.Variation in residual PITX2 activity underlies the phenotypic spectrum of anterior segment developmental disorders..Hum Mol Genet2000;9:2131-9

[327] Espinoza HM,Vadlamudi U.Protein kinase C phosphorylation modulates N- and C-terminal regulatory activities of the PITX2 homeodomain protein..Biochemistry2005;44:3942-54

[328] Collins MM,Dufourcq P,Blader P.Pitx2c orchestrates embryonic axis extension via mesendodermal cell migration..Elife2018;7: PMCID:PMC6023614

[329] Vela I,Zhang X.PITX2 and non-canonical Wnt pathway interaction in metastatic prostate cancer..Clin Exp Metastasis2014;31:199-211

[330] Huang Y,Boskovic G.Proteomic and genomic analysis of PITX2 interacting and regulating networks..FEBS Lett2009;583:638-42 PMCID:PMC2667122

[331] Liu Y,Fan J.PITX2 associates with PTIP-containing histone H3 lysine 4 methyltransferase complex..Biochem Biophys Res Commun2014;444:634-7 PMCID:PMC3963365

[332] Simard A,Amen M,Amendt BA.The Pitx2c N-terminal domain is a critical interaction domain required for asymmetric morphogenesis..Dev Dyn2009;238:2459-70 PMCID:PMC3014603

[333] Yu W,Sweat Y.Pitx2-Sox2-Lef1 interactions specify progenitor oral/dental epithelial cell signaling centers..Development2020;147: PMCID:PMC7286298

[334] Berry FB,Oas JM.Functional interactions between FOXC1 and PITX2 underlie the sensitivity to FOXC1 gene dose in Axenfeld-Rieger syndrome and anterior segment dysgenesis..Hum Mol Genet2006;15:905-19

[335] Yang Z,Fan Z.Single-cell Sequencing Reveals Variants in ARID1A, GPRC5A and MLL2 Driving Self-renewal of Human Bladder Cancer Stem Cells..Eur Urol2017;71:8-12

[336] Bitarte N,Boni V.MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells..Stem Cells2011;29:1661-71

[337] Chen Z,Huang C.MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/beta-catenin pathway in hepatocellular carcinoma cells..Cell Signal2013;25:2693-701

[338] Liang C,Li YY,Zhang F.miR-33a suppresses the nuclear translocation of beta-catenin to enhance gemcitabine sensitivity in human pancreatic cancer cells..Tumour Biol2015;36:9395-403

[339] Ghosh RD,Das P.MicroRNA profiling of cisplatin-resistant oral squamous cell carcinoma cell lines enriched with cancer-stem-cell-like and epithelial-mesenchymal transition-type features..Sci Rep2016;6:23932 PMCID:PMC4820705

[340] Zhou H,Zhang Y.miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression..Cell Prolif2017;50: PMCID:PMC6529089

[341] Cao F.miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/beta-catenin pathway..Exp Mol Pathol2019;106:34-43

[342] Liu Z.LncRNA plasmacytoma variant translocation 1 is an oncogene in bladder urothelial carcinoma..Oncotarget2017;8:64273-82 PMCID:PMC5610001

[343] Guo F,Guo H.The action mechanism of lncRNA-HOTAIR on the drug resistance of non-small cell lung cancer by regulating Wnt signaling pathway..Exp Ther Med2018;15:4885-9 PMCID:PMC5958754

[344] Kang Y,Cao W,Sun L.Knockdown of LncRNA CRNDE suppresses proliferation and P-glycoprotein-mediated multidrug resistance in acute myelocytic leukemia through the Wnt/beta-catenin pathway..Biosci Rep2020;40: PMCID:PMC7273914

[345] Flahaut M,Coulon A.The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway..Oncogene2009;28:2245-56

[346] Wang YH,Shiseki M,Motoji T.Knockdown of the Wnt receptor Frizzled-1 (FZD1) reduces MDR1/P-glycoprotein expression in multidrug resistant leukemic cells and inhibits leukemic cell proliferation..Leuk Res2018;67:99-108

[347] Zhang H,Wu X.Interference of Frizzled 1 (FZD1) reverses multidrug resistance in breast cancer cells through the Wnt/beta-catenin pathway..Cancer Lett2012;323:106-13

[348] Liu X,Ma W.Knockdown of frizzled-7 inhibits cell growth and metastasis and promotes chemosensitivity of esophageal squamous cell carcinoma cells by inhibiting Wnt signaling..Biochem Biophys Res Commun2017;490:1112-8

[349] Chen Z,Ma T.Reversal effect of quercetin on multidrug resistance via FZD7/beta-catenin pathway in hepatocellular carcinoma cells..Phytomedicine2018;43:37-45

[350] Zhang K,Huang H.Dishevelled1-3 contribute to multidrug resistance in colorectal cancer via activating Wnt/beta-catenin signaling..Oncotarget2017;8:115803-16 PMCID:PMC5777814

[351] Ku JL,Kim DW.Establishment and characterization of 13 human colorectal carcinoma cell lines: mutations of genes and expressions of drug-sensitivity genes and cancer stem cell markers..Carcinogenesis2010;31:1003-9

[352] Chikazawa N,Tasaka T.Inhibition of Wnt signaling pathway decreases chemotherapy-resistant side-population colon cancer cells..Anticancer Res2010;30:2041-8

[353] Correa S,Du Rocher B,Pizzatti L.Wnt/beta-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia..BMC Cancer2012;12:303 PMCID:PMC3464798

[354] Stein U,Siegel F.Impact of mutant beta-catenin on ABCB1 expression and therapy response in colon cancer cells..Br J Cancer2012;106:1395-405 PMCID:PMC3327894

[355] Xia Z,Liu H.CBP-dependent Wnt/beta-catenin signaling is crucial in regulation of MDR1 transcription..Curr Cancer Drug Targets2015;15:519-32

[356] Zhang ZM,Luo QC.Pygo2 activates MDR1 expression and mediates chemoresistance in breast cancer via the Wnt/beta-catenin pathway..Oncogene2016;35:4787-97

[357] Zhou C,Qin W.Pygopus2 inhibits the efficacy of paclitaxel-induced apoptosis and induces multidrug resistance in human glioma cells..Oncotarget2017;8:27915-28 PMCID:PMC5438618